GGrantIndex
← Leaderboards

David Serre

University Of Maryland Baltimore

$13,109,756
Attributed
$13,544,937
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY201125
$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,544,937 · 10

By mechanism

R01$11,383,549 · 5
R21$2,161,388 · 5

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “Parasites

Research focus

ParasitesResponseMalariaInfectionPlasmodium VivaxVivax MalariaGenesLiverGenomicsBloodGene ExpressionPlasmodium FalciparumLaboratoriesAreaBiologyInsightCambodiaBlood SpecimenMolecularVariantBasePatternIn VivoGenome-Wide

Grant awards (33)

Multi-Omics Characterization of Plasmodium Vivax Hypnozoites$688,160
R01 · FY2025 · AI · contact PI
Host and parasite factors influencing P. vivax RBC invasion and asexual development$536,141
R01 · FY2025 · AI · contact PI
Characterization of Plasmodium falciparum long non-coding RNAs and their roles in gene regulation$445,488
R21 · FY2025 · AI · contact PI
Host and parasite factors influencing P. vivax RBC invasion and asexual development$154,170
R01 · FY2025 · AI · contact PI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites$705,012
R01 · FY2024 · AI · contact PI
Host and parasite factors influencing P. vivax RBC invasion and asexual development$691,533
R01 · FY2024 · AI · contact PI
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure$503,963
R01 · FY2024 · AI · contact PI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites$725,059
R01 · FY2023 · AI · contact PI
Host and parasite factors influencing P. vivax RBC invasion and asexual development$706,316
R01 · FY2023 · AI · contact PI
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure$574,672
R01 · FY2023 · AI · contact PI
Host and parasite factors influencing P. vivax RBC invasion and asexual development$660,178
R01 · FY2022 · AI · contact PI
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure$644,275
R01 · FY2022 · AI · contact PI
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array$231,750
R21 · FY2022 · AI · contact PI
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure$639,640
R01 · FY2021 · AI · contact PI
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array$193,125
R21 · FY2021 · AI · contact PI
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure$642,230
R01 · FY2020 · AI · contact PI
Host and Parasite Transcriptional Changes Associated with Immunity to Clinical Malaria in Malian Children$193,125
R21 · FY2020 · AI · contact PI
Comprehensive Characterization of Intestinal Parasites in Infants and Their Impact on Diarrhea$193,125
R21 · FY2020 · AI · contact PI
Are all sporozoites equal? Analyses of transcriptomes from individual Plasmodium sporozoites using single cell RNA-seq$193,125
R21 · FY2020 · AI · contact PI
Are all sporozoites equal? Analyses of transcriptomes from individual Plasmodium sporozoites using single cell RNA-seq$248,150
R21 · FY2019 · AI · contact PI
Host and Parasite Transcriptional Changes Associated with Immunity to Clinical Malaria in Malian Children$231,750
R21 · FY2019 · AI · contact PI
Comprehensive Characterization of Intestinal Parasites in Infants and Their Impact on Diarrhea$231,750
R21 · FY2019 · AI · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$354,997
R01 · FY2017 · AI · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$266,005
R01 · FY2016 · AI · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$88,078
R01 · FY2016 · AI · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$357,971
R01 · FY2015 · AI · contact PI
Molecular Basis and Consequences of Early Developmental Epigenetic Programming$341,475
R01 · FY2015 · DK · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$358,729
R01 · FY2014 · AI · contact PI
Molecular Basis and Consequences of Early Developmental Epigenetic Programming$341,475
R01 · FY2014 · DK · contact PI
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia$339,971
R01 · FY2013 · AI · contact PI
Molecular Basis and Consequences of Early Developmental Epigenetic Programming$329,524
R01 · FY2013 · DK · contact PI
Molecular Basis and Consequences of Early Developmental Epigenetic Programming$341,475
R01 · FY2012 · DK · contact PI
Molecular Basis and Consequences of Early Developmental Epigenetic Programming$392,500
R01 · FY2011 · DK · contact PI